The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 1, 2010, Pages 95-105

  Kirchhefer, Uwe ^a   Wehrmeister, Diana ^a   Postma, Alex V ^b   Pohlentz, Gottfried ^a   Mormann, Michael ^a   Kucerova, Dana ^a   Müller, Frank U ^a   Schmitz, Wilhelm ^a   Schulze Bahr, Eric ^a   Wilde, Arthur A ^b   Neumann, Joachim ^c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Arrhythmias; Ca2+ handling; Calsequestrin; Mutation; Sarcoplasmic reticulum

Indexed keywords

CAFFEINE; CALCIUM; CALCIUM CHANNEL; CALSEQUESTRIN; CELL PROTEIN; RYANODINE RECEPTOR; TRIADIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM BINDING; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL LINE; CONTROLLED STUDY; EUKARYOTE; GENE EXPRESSION; GLYCOSYLATION; HEART MUSCLE CELL; HETEROZYGOSITY; HYPERGLYCOSYLATION; MISSENSE MUTATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; SARCOPLASMIC RETICULUM;

ARRHYTHMIAS, CARDIAC; CALCIUM; CALCIUM, DIETARY; CALSEQUESTRIN; CARRIER PROTEINS; CELLS; HUMANS; MUSCLE CELLS; MUSCLE PROTEINS; MUTATION; MUTATION, MISSENSE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; TACHYCARDIA, VENTRICULAR;

EUKARYOTA;

EID: 77953358881     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.03.006     Document Type: Article

References (45)

1. Leenhardt A., Lucet V., Denjoy I., Grau F., Dongoc D., Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children - a 7-year follow-up of 21 patients. Circulation 1995, 91:1512-1519.
2. Lahat H., Pras E., Olender T., Avidan N., Ben Asher E., Man O., et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001, 69:1378-1384.
3. Postma A.V., Denjoy I., Hoorntje T.M., Lupoglazoff J.M., Da Costa A., Sebillon P., et al. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2002, 91:E21-E26.
4. di Barletta M.R., Viatchenko-Karpinski S., Nori A., Memmi M., Terentyev D., Turcato F., et al. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. Circulation 2006, 114:1012-1019.
5. Terentyev D., Nori A., Santoro M., Viatchenko-Karpinski S., Kubalova Z., Gyorke I., et al. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ Res 2006, 98:1151-1158.
6. O'Brian J.J., Ram M.L., Kiarash A., Cala S.E. Mass spectrometry of cardiac calsequestrin characterizes microheterogeneity unique to heart and indicative of complex intracellular transit. J Biol Chem 2002, 277:37154-37160.
7. Wang S.R., Trumble W.R., Liao H., Wesson C.R., Dunker A.K., Kang C.H. Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum. Nat Struct Biol 1998, 5:476-483.
8. Gatti G., Trifari S., Mesaeli N., Parker J.M.R., Michalak M., Meldolesi J. Head-to-tail oligomerization of calsequestrin: a novel mechanism for heterogeneous distribution of endoplasmic reticulum luminal proteins. J Cell Biol 2001, 154:525-534.
9. Park H.J., Park I.Y., Kim E.J., Youn B.Y., Fields K., Dunker A.K., et al. Comparing skeletal and cardiac calsequestrin structures and their calcium binding - a proposed mechanism for coupled calcium binding and protein polymerization. J Biol Chem 2004, 279:18026-18033.
10. Zhang L., Kelley J., Schmeisser G., Kobayashi Y.M., Jones L.R. Complex formation between junction, triadin, calsequestrin, and the ryanodine receptor - proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 1997, 272:23389-23397.
11. Kobayashi Y.M., Alseikhan B.A., Jones L.R. Localization and characterization of the calsequestrin-binding domain of triadin 1 - evidence for a charged beta-strand in mediating the protein-protein interaction. J Biol Chem 2000, 275:17639-17646.
12. Viatchenko-Karpinski S., Terentyev D., Gyorke I., Terentyeva R., Volpe P., Priori S.G., et al. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res 2004, 94:471-477.
13. Terentyev D., Kubalova Z., Valle G., Nori A., Vedamoorthyrao S., Terentyeva R., et al. Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death. Biophys J 2008, 95:2037-2048.
14. Postma A.V., Denjoy I., Kamblock J., Alders M., Lupoglazoff J.M., Vaksmann G., et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet 2005, 42:863-870.
15. He T.C., Zhou S.B., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998, 95:2509-2514.
16. Poindexter B.J., Smith J.R., Buja L.M., Bick R.J. Calcium signaling mechanisms in dedifferentiated cardiac myocytes: comparison with neonatal and adult cardiomyocytes. Cell Calcium 2001, 30:373-382.
17. Kliche K., Kuhn M., Hillebrand U., Ludwig Y., Stock C., Oberleithner H. Direct aldosterone action on mouse cardiomyocytes detected with atomic force microscopy. Cell Physiol Biochem 2006, 18:265-274.
18. Mormann M., Eble J., Schwoeppe C., Mesters R.M., Berdel W.E., Peter-Katalinic J., et al. Fragmentation of intra-peptide and inter-peptide disulfide bonds of proteolytic peptides by nanoESI collision-induced dissociation. Anal Bioanal Chem 2008, 392:831-838.
19. Henning S., Peter-Katalinic J., Pohlentz G. Structure elucidation of glycoproteins by direct nanoESI MS and MS/MS analysis of proteolytic glycopeptides. J Mass Spectrom 2007, 42:1415-1421.
20. Kirchhefer U., Neumann J., Baba H.A., Begrow F., Kobayashi Y.M., Reinke U., et al. Cardiac hypertrophy and impaired relaxation in transgenic mice overexpressing triadin 1. J Biol Chem 2001, 276:4142-4149.
21. Jones L.R., Zhang L., Sanborn K., Jorgensen A.O., Kelley J. Purification, primary structure, and immunological characterization of the 26-kDa calsequestrin binding protein (junctin) from cardiac junctional sarcoplasmic reticulum. J Biol Chem 1995, 270:30787-30796.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
23. Jones L.R., Suzuki Y.J., Wang W., Kobayashi Y.M., Ramesh V., Franzini-Armstrong C., et al. Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest 1998, 101:1385-1393.
24. Gergs U., Berndt T., Buskase J., Jones L.R., Kirchhefer U., Muller F.U., et al. On the role of junctin in cardiac Ca2+ handling, contractility, and heart failure. Am J Physiol 2007, 293:H728-H734.
25. Gombosova I., Boknik P., Kirchhefer U., Knapp J., Luss H., Muller F.U., et al. Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatases. Am J Physiol 1998, 274:H2123-H2132.
26. Helenius A., Aebi M. Intracellular functions of N-linked glycans. Science 2001, 291:2364-2369.
27. Houle T.D., Ram M.L., McMurray W.J., Cala S.E. Different endoplasmic reticulum trafficking and processing pathways for calsequestrin (CSQ) and epitope-tagged CSQ. Exp Cell Res 2006, 312:4150-4161.
28. Maguire P.B., Briggs F.N., Lennon N.J., Ohlendieck K. Oligomerization is an intrinsic property of calsequestrin in normal and transformed skeletal muscle. Biochem Biophys Res Commun 1997, 240:721-727.
29. Park H.J., Wu S., Dunker A.K., Kang C. Polymerization of calsequestrin - implications for Ca2+ regulation. J Biol Chem 2003, 278:16176-16182.
30. Gyorke I., Hester N., Jones L.R., Gyorke S. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. Biophys J 2004, 86:2121-2128.
31. De la Fuente S., Van Langen I.M., Postma A.V., Bikker H., Meijer A. A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations. PACE 2008, 31:916-919.
32. Kiarash A., Kelly C.E., Phinney B.S., Valdivia H.H., Abrams J., Cala S.E. Defective glycosylation of calsequestrin in heart failure. Cardiovasc Res 2004, 63:264-272.
33. Nori A., Valle G., Massimino M.L., Volpe P. Targeting of calsequestrin to the sarcoplasmic reticulum of skeletal muscle upon deletion of its glycosylation site. Exp Cell Res 2001, 265:104-113.
34. Houle T.D., Ram M.L., Cala S.E. Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium. Cardiovasc Res 2004, 64:227-233.
35. Valle G., Galla D., Nori A., Priori S.G., Gyorke S., De Filippis V., et al. Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin. Biochem J 2008, 413:291-303.
36. Qin J., Valle G., Nani A., Nori A., Rizzi N., Priori S.G., et al. Luminal Ca2+ regulation of single cardiac ryanodine receptors: insights provided by calsequestrin and its mutants. J Gen Physiol 2008, 131:325-334.
37. Meissner G. Ryanodine receptor Ca2+ release channels and their regulation by endogenous effectors. Ann Rev Physiol 1994, 56:485-508.
38. Rizzi N., Liu N., Napolitano C., Nori A., Turcato F., Colombi B., et al. Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin - a complex arrhythmogenic cascade in a knock in mouse model. Circ Res 2008, 103:298-306.
39. Song L., Alcalai R., Arad M., Wolf C.M., Toka O., Conner D.A., et al. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2007, 117:1814-1823.
40. Dirksen W.P., Lacombe V.A., Chi M., Kalyanasundaram A., Viatchenko-Karpinski S., Terentyev D., et al. A mutation in calsequestrin, CASQ2 (D307H), impairs sarcoplasmic reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice. Cardiovasc Res 2007, 75:69-78.
41. Knollmann B.C., Chopra N., Hlaing T., Akin B., Yang T., Ettensohn K., et al. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2006, 116:2510-2520.
42. Haddock P.S., Coetzee W.A., Cho E., Porter L., Katoh H., Bers D.M., et al. Subcellular [Ca2+](i) gradients during excitation-contraction coupling in newborn rabbit ventricular myocytes. Circ Res 1999, 85:415-427.
43. Tohse N., Seki S., Kobayashi T., Tsutsuura M., Nagashima M., Yamada Y. Development of excitation-contraction coupling in cardiomyocytes. Japan J Physiol 2004, 54:1-6.
44. Cohen N.M., Lederer W.J. Changes in the calcium current of rat-heart ventricular myocytes during development. J Physiol-London 1988, 406:115-146.
45. Artman M., Ichikawa H., Avkiran M., Coetzee W.A. Na+/Ca2+ exchange current density in cardiac myocytes from rabbits and guinea-pigs during postnatal development. Am J Physiol 1995, 37:H1714-H1722.